| Product Code: ETC11489342 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Cannabis Pharmaceuticals Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Australia Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Australia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Australia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Australia Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Australia Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in Australia |
4.2.2 Growing research and development activities in the cannabis pharmaceuticals sector |
4.2.3 Favorable government regulations and policies supporting the use of medical cannabis |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance issues in the cannabis pharmaceuticals market |
4.3.2 Limited insurance coverage for medical cannabis products in Australia |
5 Australia Cannabis Pharmaceuticals Market Trends |
6 Australia Cannabis Pharmaceuticals Market, By Types |
6.1 Australia Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 Australia Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 Australia Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Australia Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Australia Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 Australia Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 Australia Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Australia Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 Australia Cannabis Pharmaceuticals Market Imports from Major Countries |
8 Australia Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of clinical trials conducted on cannabis-based pharmaceuticals in Australia |
8.2 Adoption rate of medical cannabis prescriptions by healthcare professionals |
8.3 Number of new cannabis pharmaceutical products introduced to the market |
8.4 Patient satisfaction and reported health improvements from using medical cannabis |
9 Australia Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 Australia Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Australia Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Australia Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Australia Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 Australia Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Australia Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here